Blockchain
Tendonitis Treatment Market Size Worth $235.4 Billion By 2028: Grand View Research, Inc.
![](https://theblockchainexaminer.com/wp-content/uploads/2021/10/13.jpg)
The global tendonitis treatment market size is expected to reach USD 235.4 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.8% from 2021 to 2028. Individuals are proactively participating in sporting or physical activities and the probability of sports-related injuries occurring is rising, thereby contributing to the market development and growth. The growing global geriatric population is susceptible to tendonitis or could be suffering from bone disorders, osteoporosis, rheumatoid arthritis, diabetes, and osteoarthritis. Constant innovation of technologies and therapies in treating tendonitis is contributing to the growth. Supportive government initiatives and significant investments and collaborations amongst key players to expand product offerings are boosting the market growth.
Key Insights & Findings:
- The market is expected to grow well over the forecast period owing to the increasing prevalence of tendonitis and the introduction of new and innovative therapies
- The therapy segment dominated the market in 2020 due to the rising occurrence of sports injuries and rising awareness levels towards non-pharmacological therapies and easy availability
- The Achilles tendonitis segment dominated the market in 2020 due to the high occurrence of the medical condition in both competitive and recreational sports players
Read 120 page market research report, “Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment, By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Swimmer’s Shoulder), By Region, And Segment Forecasts, 2021 – 2028“, by Grand View Research
Over the past years, the growing reliance on technologies in mapping various factors concerning sports, such as performance assessment, training modules, and sports injuries tracking and monitoring. The shift from proactive to preventive therapies is proving to be beneficial in improving the health status of sports players to prevent injuries. Sporting and physical activities are witnessing significant participation, and this paves way for possibilities of incurring sports injuries. As per Standard Children’s Health, in 2018, out of 30.0 million children and adolescents participating in sports in the U.S., approximately 3.5 million incur some form of sports injury. Furthermore, nearly 775,000 children and adolescents are treated for sports-related injuries in the U.S. every year. Thus, increased participation in sporting activities coupled with the growing adoption of treatment facilities is expected to boost market growth over the forthcoming years.
The key players are increasingly investing in the development of new innovative products to upgrade their product portfolios. The companies are developing products to cater to the growing incidences of sports injury in both competitive and recreational sports players. Market leaders are implementing strategic decisions to gain a competitive edge in the market. Key players are focusing on strengthening their business position in both developed and emerging economies, focusing on product innovation, and supplement organic growth through acquisitions. For instance, in March 2019, Stryker acquired OrthoSpace Ltd. to expand its existing sporting medicine and therapy segment.
The emergence of the Covid-19 pandemic has altered the methods of care delivery in treating tendonitis. Due to the temporary lockdowns, travel restrictions, and high infection load in the healthcare facilities, the market has been negatively impacted. The shortage of skilled healthcare personnel treating tendonitis has restrained the development and growth of the pandemic. Cancellation or postponement of sports injuries implies a decline of sports injuries, which eventually negatively influences the business revenue earnings. The decline in non-pharmacological therapies and surgeries is hindering the market growth.
Grand View Research, Inc. has segmented the global tendonitis treatment market on the basis of treatment, condition, and region:
- Tendonitis Treatment Outlook (Revenue, USD Million, 2016 – 2028)
- Therapy
- Hot and Cold Therapy
- Physical Therapy
- Shockwave Therapy
- Surgery
- Therapy
- Tendonitis Treatment Condition Outlook (Revenue, USD Million, 2016 – 2028)
- Tennis Elbow
- Golfer’s Elbow
- Pitcher’s Elbow
- Jumper’s Knee
- Swimmer’s Shoulder
- Achilles Tendonitis
- Tendonitis Treatment Regional Outlook (Revenue, USD Million, 2016 – 2028)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Spain
- Italy
- France
- Russia
- Asia Pacific
- Japan
- China
- India
- Singapore
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- North America
List of Key Players of Tendonitis Treatment Market
- Merck and Co., Inc.
- AstraZeneca
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Abbott
- Pfizer
- Bayer AG
- GlaxoSmithKline PLC
- Almatica Pharma, Inc.
- Teva Pharmaceuticals Industries
Check out more studies related to bone disorders, their diagnostics & treatment, conducted by Grand View Research:
- Orthopedic Biomaterials Market – The global orthopedic biomaterials market size was valued at USD 11.96 billion in 2018 and is anticipated to expand at a CAGR of 10.3% over the forecast period. Increasing incidence of musculoskeletal ailments and chronic skeletal conditions is boosting the product demand, thereby augmenting the market growth.
- Orthopedic Regenerative Surgical Products Market – The global orthopedic regenerative surgical products market size was valued at USD 3.4 billion in 2020 and is estimated to expand at a compound annual growth rate (CAGR) of 3.6% from 2021 to 2028. Growing technological advancements, the prevalence of arthritis and other orthopedic conditions, orthopedic surgeries, and R&D activities are some of the key drivers of this market.
- Rheumatoid Arthritis Therapeutics Market – he global rheumatoid arthritis therapeutics market size was valued at USD 20.3 billion in 2016. The market is anticipated to expand at a CAGR of 4.6% over the forecast period. Increasing prevalence of arthritis, growing acceptance of biopharmaceuticals, and the presence of well-defined regulatory guidelines in developed economies are among the key trends expected to trigger market growth.
Blockchain
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution
Blockchain
Ethereum ETFs Aren’t Blockchain But Is A Revolutionary Tech: Top 6 Amazing Reasons To Invest In Them
![ethereum-etfs-aren’t-blockchain-but-is-a-revolutionary-tech:-top-6-amazing-reasons-to-invest-in-them](https://theblockchainexaminer.com/wp-content/uploads/2024/07/51834-ethereum-etfs-arent-blockchain-but-is-a-revolutionary-tech-top-6-amazing-reasons-to-invest-in-them.png)
The financial landscape is rapidly evolving, with the integration of blockchain technology and cryptocurrencies becoming more prominent. Among these, Ethereum ETFs (Exchange-Traded Funds) have emerged as a significant investment vehicle, offering exposure to the Ethereum blockchain’s native cryptocurrency, Ether (ETH), without requiring direct ownership. However, it’s crucial to understand that Ethereum ETFs are distinct from the blockchain itself and serve different purposes in the investment world.
Understanding Ethereum and ETFs
Ethereum: A decentralized platform that enables the creation and execution of smart contracts and decentralized applications (dApps). It operates using its cryptocurrency, Ether (ETH), which fuels the network.
ETF (Exchange-Traded Fund): A type of investment fund that holds a collection of assets and is traded on stock exchanges. ETFs can include various asset classes, such as stocks, commodities, or bonds.
Ethereum ETFs: The Intersection of Traditional Finance and Cryptocurrency
An Ethereum ETF provides a way for investors to gain exposure to the price movements of Ether without directly purchasing the cryptocurrency. This is achieved through an ETF structure, where the fund holds assets linked to the value of Ether, and investors can buy shares of the ETF on traditional stock exchanges.
Key Features of Ethereum ETFs:
- Indirect Exposure: Investors gain exposure to Ether’s price changes without needing to manage or store the cryptocurrency themselves.
- Regulatory Compliance: Unlike the relatively unregulated cryptocurrency market, ETFs operate under the oversight of financial regulators, offering a layer of investor protection.
- Accessibility: Ethereum ETFs are available through traditional brokerage platforms, making them accessible to a broader range of investors.
Why Invest in an Ethereum ETF?
- Diversification: Including an Ethereum ETF in a portfolio can provide exposure to the cryptocurrency market, potentially enhancing diversification beyond traditional assets.
- Convenience and Familiarity: ETFs are a familiar investment product, simplifying the process of investing in cryptocurrencies.
- Professional Management: ETF managers handle the investment decisions, including the buying and selling of assets, which can be advantageous for those less familiar with the cryptocurrency space.
- Regulatory Oversight: ETFs are subject to regulatory scrutiny, potentially offering more safety and transparency compared to direct cryptocurrency investments.
- Potential for Growth: As the cryptocurrency market grows, ETFs linked to assets like Ether may benefit from rising prices.
Key Differences Between Ethereum and Ethereum ETFs
While both are related to the Ethereum blockchain, Ethereum itself and Ethereum ETFs represent different forms of investment:
- Ethereum (ETH):
- Direct ownership of the cryptocurrency.
- Full exposure to Ethereum’s features, including staking and network participation.
- Traded on cryptocurrency exchanges.
- Highly volatile and largely unregulated.
- Ethereum ETF:
- Indirect exposure through shares representing Ether’s value.
- Traded on traditional stock exchanges under regulatory oversight.
- Offers a more stable and familiar investment structure.
- Typically lower volatility compared to direct cryptocurrency ownership.
Future Considerations for Ethereum ETFs
The approval and launch of Ethereum ETFs mark a significant milestone in bringing cryptocurrencies closer to mainstream finance. They offer a convenient and regulated means for investors to gain exposure to the growing digital assets market. However, they also come with limitations, such as not allowing direct participation in the Ethereum ecosystem’s innovations, like dApps and smart contracts.
As the market evolves, we may see more sophisticated financial products that better capture the full potential of the Ethereum ecosystem. For now, Ethereum ETFs provide a balanced option for those interested in cryptocurrency exposure within the framework of traditional finance.
In conclusion, while Ethereum ETFs offer a gateway into the world of digital assets, they should be viewed as complementary to, rather than a replacement for, direct investment in the underlying blockchain technologies. Investors should carefully consider their investment goals, risk tolerance, and the unique attributes of both Ethereum and Ethereum ETFs when making investment decisions.
Source: blockchainmagazine.net
The post Ethereum ETFs Aren’t Blockchain But Is A Revolutionary Tech: Top 6 Amazing Reasons To Invest In Them appeared first on HIPTHER Alerts.
Blockchain
Nexo Reaffirms Commitment to Data Protection with SOC 3 and SOC 2 Compliance
![nexo-reaffirms-commitment-to-data-protection-with-soc-3-and-soc-2-compliance](https://theblockchainexaminer.com/wp-content/uploads/2024/07/51836-nexo-reaffirms-commitment-to-data-protection-with-soc-3-and-soc-2-compliance.png)
Nexo, a leading institution in the digital assets industry, has reinforced its commitment to data security by renewing its SOC 2 Type 2 audit and attaining a new SOC 3 Type 2 assessment without any exceptions. This rigorous audit process, conducted by A-LIGN, a respected independent auditor specializing in security compliance, confirms Nexo’s adherence to stringent Trust Service Criteria for Security and Confidentiality.
Key Achievements and Certifications
- SOC 2 and SOC 3 Compliance:
- SOC 2 Type 2: This audit evaluates and reports on the effectiveness of an organization’s controls over data security, particularly focusing on the confidentiality, integrity, and availability of systems and data.
- SOC 3 Type 2: This public-facing report provides a summary of SOC 2 findings, offering assurance to customers and stakeholders about the robustness of Nexo’s data security practices.
- Additional Trust Service Criteria:
- Nexo expanded the scope of these audits to include Confidentiality, showcasing a deep commitment to protecting user data.
- Security Certifications:
- The company also adheres to the CCSS Level 3 Cryptocurrency Security Standard, and holds ISO 27001, ISO 27017, and ISO 27018 certifications, awarded by RINA. These certifications are benchmarks for security management and data privacy.
- CSA STAR Level 1 Certification:
- This certification demonstrates Nexo’s adherence to best practices in cloud security, further solidifying its position as a trusted partner in the digital assets sector.
Impact on Customers and Industry Standards
Nexo’s rigorous approach to data protection and compliance sets a high standard in the digital assets industry. By achieving these certifications, Nexo provides its over 7 million users across more than 200 jurisdictions with confidence in the security of their data. These achievements not only emphasize the company’s dedication to maintaining top-tier security standards but also highlight its proactive stance in fostering trust and transparency in digital asset management.
Nexo’s Broader Mission
As a premier institution for digital assets, Nexo offers a comprehensive suite of services, including advanced trading solutions, liquidity aggregation, and tax-efficient credit lines backed by digital assets. Since its inception, the company has processed over $130 billion, showcasing its significant impact and reliability in the global market.
In summary, Nexo’s successful completion of SOC 2 and SOC 3 audits, along with its comprehensive suite of certifications, underscores its commitment to the highest standards of data security and operational integrity. This dedication positions Nexo as a leader in the digital assets space, offering unparalleled security and peace of mind to its users.
Source: blockchainreporter.net
The post Nexo Reaffirms Commitment to Data Protection with SOC 3 and SOC 2 Compliance appeared first on HIPTHER Alerts.
-
Blockchain4 days ago
Binance Cleared to Invest Customer Assets in US Treasury Bills: What It Means for Crypto and Dollar Dominance
-
Blockchain4 days ago
Deep Custodian Limited Obtains Hong Kong TCSP License, Authorized to Provide Compliant Crypto Asset Custody Services
-
Blockchain2 days ago
Blockchain Intelligence Group adds additional modules and launches its Certified Cryptocurrency Investigator – Advanced Series
-
Blockchain Press Releases2 days ago
Bybit Web3 Livestream Explores Cultural Meme Coins and Other Trends
-
Blockchain3 days ago
BitAngels Network Hosts Blockchain Pitch Competition in Nashville
-
Blockchain Press Releases2 days ago
Bybit Surges to Second Place in Derivatives Market, Solidifying Position as Global Crypto Trading Leader
-
Blockchain4 days ago
CoinW Continues Expedition Trek And Double Down On Presence At ETH-Native Events
-
Blockchain1 day ago
Kevin O ‘Leary Addresses Crypto Investing, Ethereum ETFs, and SEC Chair in Recent Interview